WNK2 and breast cancer: E2 activation of GPER leads to transactivation of the Epidermal Growth Factor Receptor (EGFR) and downstream activation of Mitogen-activated protein kinase (MAPK) and Phosphoinositide 3-kinase (PI3K) signaling cascades in breast cancer cells [36].